Position in ACB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$318
-$12 QoQ
Shares Held
114
+12.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 149 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. ACB ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in ACB
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $318 | 114 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $330 | 101 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $476 | 113 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $673 | 113 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $428 | 101 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4 | 1 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4 | 1 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5 | 1 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4 | 1 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $4 | 1 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6 | 14 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8 | 14 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7 | 14 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9 | 14 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $12 | 14 | Shares | Sole | 2023-02-24 | |
| 2021-09-30 | $96 | 14 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $126 | 14 | Shares | Sole | 2021-08-02 | |
| 2020-03-31 | $13,752 | 15,179 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||